Pharmaceutical patents are notoriously long and complex. It’s not uncommon for scientists or analysts to spend days—or even weeks—manually reviewing a single 300-page patent just to extract a few key molecules or data points.
But what if this process could be reduced to minutes?
The Problem with Manual Pharmaceutical Patent Analysis
Traditional patent analysis involves:
- Traditional workflows often start with manual searches on Google Patents, reading full documents line by line
- Manually extracting chemical structures, Researchers often rely on databases like PubChem to identify chemical compounds
- Cross-checking biological data
This leads to:
- Slow decision-making
- Missed insights
- High labor costs
A Faster Approach: AI for pharmaceutical patent analysis
Instead of manually parsing patents, AI can:
- Identify core molecules instantly
- Extract bioactivity data (e.g., EC50, IC50)
- Summarize key claims and innovations
For example, with AI-powered tools like Eureka LS Lead Compound Agent:
- A full patent can be analyzed in under 3 minutes
- Key compounds and their performance are automatically highlighted
Real Impact
Instead of:
Spending 1 week reading a patent
You can:
Get a structured, decision-ready report in minutes
How It Works?
- Upload patent or input drug name
- AI scans and parses full document
- Extracts:
- Key molecules
- Biological data
- Structure (SMILES)
- Generates summary report
Now You Can?
👉 Stop reading patents manually.
👉 Start analyzing them in minutes.
Try AI-powered patent analysis with free credits today → Eureka LS
